MPO and neoplasm: In mice, CD11b+Ly6G+Ly6Clow G‐MDSCs acquire higher arginase and MPO activity, as well as increased ROS production in tumor‐bearing mice compared to CD11b+Ly6G+Ly6Clow neutrophils from naive tumor‐free mice, which mediates tumor immunosuppression.119